Literature DB >> 25422437

Going viral and the fatal vulnerability of neurons from immunity, not from infection.

Lawrence Steinman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25422437      PMCID： PMC4260614          DOI： 10.1073/pnas.1420310111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Ivorlyne P Greene; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Pathogenesis of poliomyelitis.

Authors:  D BODIAN
Journal:  Am J Public Health Nations Health       Date:  1952-11

3.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

4.  Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists.

Authors:  J L Nargi-Aizenman; D E Griffin
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  The virus, the nerve cell, and paralysis; a study of experimental poliomyelitis in the spinal cord.

Authors:  D BODIAN
Journal:  Bull Johns Hopkins Hosp       Date:  1948-07

Review 6.  Immunology of relapse and remission in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Annu Rev Immunol       Date:  2014-01-15       Impact factor: 28.527

7.  In vivo treatment with anti-alpha4 integrin suppresses clinical and pathological evidence of Borna disease virus infection.

Authors:  S A Rubin; T A Yednock; K M Carbone
Journal:  J Neuroimmunol       Date:  1998-04-15       Impact factor: 3.478

8.  Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection.

Authors:  Ivorlyne P Greene; Eun-Young Lee; Natalie Prow; Brownhilda Ngwang; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

9.  The discovery of natalizumab, a potent therapeutic for multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  J Cell Biol       Date:  2012-10-29       Impact factor: 10.539
  9 in total
  1 in total

Review 1.  Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage.

Authors:  Diane E Griffin
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.